Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study

CompletedOBSERVATIONAL
Enrollment

202

Participants

Timeline

Start Date

April 29, 2016

Primary Completion Date

October 22, 2018

Study Completion Date

October 22, 2018

Conditions
Diabetic Macular Oedema
Interventions
DRUG

dexamethasone intravitreal implant

Ozurdex® treatment for diabetic macular oedema as per standard of care in clinical practice.

Trial Locations (23)

2000

Retina & Vitreous Centre City, Sydney

Sydney Eye and Retina Clinic, Sydney

Sydney Eye Hospital/Macular Diseases Centre, Sydney

2103

Eye Doctors Mona Vale, Mona Vale

2135

Retina & Vitreous Centre Strathfield, Strathfield

Strathfield Retina, Strathfield

2145

Sydney West Retina, Westmead

2150

Marsden Eye Clinic, Parramatta

2170

Retina Associates, Liverpool

2220

Retina and Macula Specialists,Hurstville, Hurtsville

2228

Retina and Macula Specialists, Miranda, Miranda

3011

Vision Eye Institute, Footscry

3040

Essendon Retina, Essendon

3065

Victoria Parade Eye Consultants, Fitzroy

4000

Terrace Eye Centre, Brisbane

4020

Peninsula Eye Hospital, Redcliffe

4101

The Qld Eye Institute, South Brisbane

4510

Caboolture Eye Surgery, Caboolture

5000

Adelaide Eye & Retina Centre, Adelaide

Department of Opthalmology, Royal Adelaide Hospital, Adelaide

Hobart Eye Surgeons, Hobart

6009

Lions Eye Institute, Nedlands

7249

Tasmanian Eye Institute, Launceston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY